Presentation is loading. Please wait.

Presentation is loading. Please wait.

Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient  Richard A. Helmers, MD, Thomas J. Byrne,

Similar presentations


Presentation on theme: "Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient  Richard A. Helmers, MD, Thomas J. Byrne,"— Presentation transcript:

1 Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient  Richard A. Helmers, MD, Thomas J. Byrne, MD, Lewis J. Wesselius, MD, Kevin O. Leslie, MD  Mayo Clinic Proceedings  Volume 90, Issue 9, Pages (September 2015) DOI: /j.mayocp Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions

2 Figure 1 Diffuse ground-glass opacities on computed tomography of the chest. Mayo Clinic Proceedings  , DOI: ( /j.mayocp ) Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions

3 Figure 2 Simeprevir-sofosbuvir–related diffuse alveolar damage. A, Diffuse alveolar damage is evident in the surgical lung biopsy specimen, with hyaline membranes (hm) readily visible. The process was not uniform, with spared areas visible (hematoxylin-eosin, original magnification ×100). B, At higher magnification, intensely vacuolated type 2 cells and macrophages (v) are present with scattered intra-alveolar eosinophils (arrow). These combined features are highly suggestive of medication toxicity (hematoxylin-eosin, original magnification ×400). Mayo Clinic Proceedings  , DOI: ( /j.mayocp ) Copyright © 2015 Mayo Foundation for Medical Education and Research Terms and Conditions


Download ppt "Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient  Richard A. Helmers, MD, Thomas J. Byrne,"

Similar presentations


Ads by Google